Haleon, the maker of Sensodyne toothpaste, announced a £175 million (approximately ₹2,000 crore) investment to establish its first oral health manufacturing plant in Madhya Pradesh, India. The facility will mark a strategic shift from contract manufacturing to in-house production in the country, which has become Haleon's second-largest oral care market globally, according to livemint.com.
The decision to build the plant follows the rapid growth of Sensodyne in India, one of the fastest-growing markets for the brand. The new manufacturing unit will enable Haleon to meet increasing demand locally and reduce reliance on third-party manufacturers. The company highlighted India’s significance in its global portfolio and plans to leverage the plant to support future growth in the region, livemint.com reported.
This investment underscores the expanding oral care market in India, which has attracted global consumer health companies. Haleon's move aligns with similar strategies by multinational firms to deepen their footprint in emerging markets by localizing production. The plant will enhance supply chain efficiency and potentially lower costs, positioning Haleon competitively against other oral care brands in India’s growing market, according to livemint.com.
The Madhya Pradesh facility is expected to be operational within the next few years, representing a major milestone for Haleon’s India operations. The company’s investment reflects the increasing importance of India in the global oral care sector, with Sensodyne’s sales growth contributing significantly to Haleon’s overall performance, livemint.com stated.